Jonathan S. Mason

2.5k citations

29 papers · 1.9k indexed · h-index 21

Impact in

Physiology top 1%
- Adenosine and Purinergic Signaling
Cellular and Molecular Neuroscience top 2%
- Neuropeptides and Animal Physiology

Papers in

Physiology 9
- Adenosine and Purinergic Signaling 9
Cellular and Molecular Neuroscience 12
- Neuropeptides and Animal Physiology 12

Co-authors: Fiona H. Marshall Miles Congreve Andrea Bortolato Benjamin G. Tehan Malcolm Weir A.S. Dore Francesca Deflorian Stephen P. Andrews
Journals: Journal of Medicinal Chemistry (6 papers)Journal of Chemical Information and Modeling (4 papers)Drug Discovery Today (2 papers)Cancer Research (2 papers)Scientific Reports (1 paper)
Partner nations: United States United Kingdom Hungary

In The Last Decade

Jonathan S. Mason

29 papers receiving 1.8k citations

Peers

Countries citing papers authored by Jonathan S. Mason

Since Specialization

Citations

This map shows the geographic impact of Jonathan S. Mason's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan S. Mason with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan S. Mason more than expected).

Fields of papers citing papers by Jonathan S. Mason

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan S. Mason. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan S. Mason. The network helps show where Jonathan S. Mason may publish in the future.

Co-authors

The 25 scholars most cited alongside Jonathan S. Mason, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jonathan S. Mason Line = papers co-authored together Jonathan S. Mason links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Identification of nanomolar adenosine A2A receptor ligands using reinforcement learning and structure-based drug design Nature Communications ·Morgan Thomas, Pierre Matricon, Zachary Roelen, 今井啓子, Stephanie Webster, Jonathan S. Mason, Jason Brown, Ratul Hasan Ankon, Naiara C. Silva, Nigel A. Swain, Angeline B. Abrenica, Noel M. O’Boyle, Francesca Deflorian, Andreas Bender, Chris de Graaf	2025	2
2	Analysis of tractable allosteric sites in G protein-coupled receptors Scientific Reports ·Amanda Wakefield, Jonathan S. Mason, Sándor Vajda, György M. Keserű	2019	36
3	Understanding Ligand Binding Selectivity in a Prototypical GPCR Family Journal of Chemical Information and Modeling ·Elloitt Holland McGinnis, Francesca Deflorian, Jonathan S. Mason, Chris de Graaf, Francesco Luigi Gervasio	2019	31
4	Structure-Based Optimization Strategies for G Protein-Coupled Receptor (GPCR) Allosteric Modulators: A Case Study from Analyses of New Metabotropic Glutamate Receptor 5 (mGlu ₅ ) X-ray Structures Journal of Medicinal Chemistry ·J.A. Christopher, LI Ya-na, Miles Congreve, A.S. Dore, James C. Errey, Fiona H. Marshall, Jonathan S. Mason, Krzysztof Okrasa, Prakash Rucktooa, María J. Serrano‐Vega, György G. Ferenczy, György M. Keserű	2018	69
5	Abstract 3751: Inhibition of A2AR by AZD4635 induces anti-tumor immunity alone and in combination with anti-PD-L1 in preclinical models Cancer Research ·Alexandra Borodovsky, Yanjun Wang, Minwei Ye, J.C. Shaw, Kris F. Sachsenmeier, Nanhua Deng, Kelly Goodwin, James Clarke, Richard J. A. Goodwin, Nicole Strittmatter, Carl Hay, Vasu R. Sah, Deborah Lawson, Corinne Reimer, Miles Congreve, Jonathan S. Mason, Fiona H. Marshall, Paul D. Lyne, Richard Woessner	2018	8
6	Impact of protein–ligand solvation and desolvation on transition state thermodynamic properties of adenosine A2A ligand binding kinetics In Silico Pharmacology ·Giuseppe Deganutti, Andrei Zhukov, Francesca Deflorian, Stephanie Federico, Giampiero Spalluto, Roger Cooke, Stefano Moro, Jonathan S. Mason, Andrea Bortolato	2017	14
7	Abstract 5580: Preclinical pharmacodynamics and antitumor activity of AZD4635, a novel adenosine 2A receptor inhibitor that reverses adenosine mediated T cell suppression Cancer Research ·Alexandra Borodovsky, Yanjun Wang, Minwei Ye, J.C. Shaw, Kris F. Sachsenmeier, Nanhua Deng, Sohibjon To‘rabekov, Adrian J. Fretland, James Clarke, Richard J. A. Goodwin, Nicole Strittmatter, Carl Hay, Vasu R. Sah, Ольга Шпилєва, Corinne Reimer, Miles Congreve, Jonathan S. Mason, Fiona H. Marshall, Paul D. Lyne, Richard Woessner	2017	19
8	Methodologies for the Examination of Water in GPCRs Methods in molecular biology ·Andrea Bortolato, Benjamin G. Tehan, R T Smith, Jonathan S. Mason	2017	5
9	Intracellular allosteric antagonism of the CCR9 receptor Nature ·Christine Oswald, Mathieu Rappas, James Kean, A.S. Dore, James C. Errey, K.A. Bennett, Francesca Deflorian, J.A. Christopher, Ali Jazayeri, Jonathan S. Mason, Miles Congreve, Roger Cooke, Fiona H. Marshall	2016	196
10	Identification of Ligand Binding Hot Spots of the Histamine H ₁ Receptor following Structure-Based Fragment Optimization Journal of Medicinal Chemistry ·Kwak Jozef, Albert J. Kooistra, Reggie Bosma, Andrea Bortolato, Maikel Wijtmans, Henry F. Vischer, Jonathan S. Mason, Chris de Graaf, Iwan J. P. de Esch, Rob Leurs	2016	24
11	Structures of G protein-coupled receptors reveal new opportunities for drug discovery Drug Discovery Today ·Roger Cooke, Alastair Brown, Fiona H. Marshall, Jonathan S. Mason	2015	99
12	Decoding the Role of Water Dynamics in Ligand–Protein Unbinding: CRF₁R as a Test Case Journal of Chemical Information and Modeling ·Andrea Bortolato, Francesca Deflorian, Dahlia R. Weiss, Jonathan S. Mason	2015	49
13	Unifying Family A GPCR Theories of Activation Pharmacology & Therapeutics ·Benjamin G. Tehan, Andrea Bortolato, Frank E. Blaney, Malcolm Weir, Jonathan S. Mason	2014	159
14	New insights from structural biology into the druggability of G protein-coupled receptors Trends in Pharmacological Sciences ·Jonathan S. Mason, Andrea Bortolato, Miles Congreve, Fiona H. Marshall	2012	131
15	Discovery of 1,2,4-Triazine Derivatives as Adenosine A_2A Antagonists using Structure Based Drug Design Journal of Medicinal Chemistry ·Miles Congreve, Stephen P. Andrews, A.S. Dore, Kaspar Hollenstein, Edward Hurrell, Christopher J. Langmead, Jonathan S. Mason, Irene W. Ng, Benjamin G. Tehan, Andrei Zhukov, Malcolm Weir, Fiona H. Marshall	2012	264
16	Identification of Novel Adenosine A_2A Receptor Antagonists by Virtual Screening Journal of Medicinal Chemistry ·Christopher J. Langmead, Stephen P. Andrews, Miles Congreve, James C. Errey, Edward Hurrell, Fiona H. Marshall, Jonathan S. Mason, Christine M. Richardson, N.J. Robertson, Andrei Zhukov, Malcolm Weir	2012	111
17	The design of combinatorial libraries using properties and 3D pharmacophore fingerprints Drug Discovery Today ·Brett R. Beno, Jonathan S. Mason	2001	27
18	Library design using BCUT chemistry-space descriptors and multiple four-point pharmacophore fingerprints: simultaneous optimization and structure-based diversity Journal of Molecular Graphics and Modelling ·Jonathan S. Mason, Brett R. Beno	2000	20
19	Chemistry Space Metrics in Diversity Analysis, Library Design, and Compound Selection Journal of Chemical Information and Computer Sciences ·Paul R. Menard, Jonathan S. Mason, Isabelle Morize, Susanne Bauerschmidt	1998	29
20	Synthesis of a stable analogue of thromboxane A1 (±)-9a-homo-(11,12)-deoxa-(11,12)-methylene thromboxane A1 Tetrahedron Letters ·M. F. Ansell, O. G. Zalugovsky, Jonathan S. Mason	1981	5

About Jonathan S. Mason

Jonathan S. Mason is a scholar working on Physiology, Cellular and Molecular Neuroscience, Computational Theory and Mathematics, Molecular Biology and Organic Chemistry, having authored 29 papers that have together received 1.9k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (19 papers), Neuropeptides and Animal Physiology (12 papers), Adenosine and Purinergic Signaling (9 papers), Chemical Synthesis and Analysis (9 papers), Computational Drug Discovery Methods (6 papers), Click Chemistry and Applications (4 papers), Oxidative Organic Chemistry Reactions (2 papers) and Synthetic Organic Chemistry Methods (2 papers). The work is most often cited by research in Physiology (283 citations), Cellular and Molecular Neuroscience (754 citations), Computational Theory and Mathematics (494 citations), Molecular Biology (1.7k citations) and Radiology, Nuclear Medicine and Imaging (328 citations). Jonathan S. Mason has collaborated with scholars based in United States, United Kingdom and Hungary. Frequent co-authors include Fiona H. Marshall, Miles Congreve, Andrea Bortolato, Benjamin G. Tehan, Malcolm Weir, A.S. Dore, Francesca Deflorian, Stephen P. Andrews, Andrei Zhukov and Roger Cooke. Their work appears in journals such as Journal of Medicinal Chemistry, Journal of Chemical Information and Modeling, Drug Discovery Today, Cancer Research and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact